Europe
Fiona Marshall founded Heptares Therapeutics, which is now one of the leading biotech companies in the UK.
Good news seems to keep coming for medtech company Medtronic.
During the presidential campaign of 2015-2016, one of the areas that got some of the largest scrutiny was drug pricing, and with good reason.
After falling short of analysts’ expectations in its latest quarter, Novo Nordisk is restructuring its commercial operations as it looks to fend off challenges to its products.
The storm cut $55-$65 million from second-quarter sales. The company previously estimated up to $250 million in costs.
Could GlaxoSmithKline’s industry-leading dividend be at risk?
Leti announced today that a team of its researchers is participating in a U.S.-funded project to develop a safe, implantable neural interface system to restore vision by stimulating the visual cortex.
The public listing is expected to value the business at around $46 billion.
The company will explore opportunity to close facilities during second half of 2019.
China revenue in Q3 increased by 12 percent at AstraZeneca and the country now accounts for 15 percent of its global product sales.
PRESS RELEASES